Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

The combined treatment of curcumin with verapamil ameliorates the cardiovascular pathology in a Williams-Beuren syndrome mouse model

  • Abdalla, Noura
  • Ortiz Romero, Paula, 1994-
  • Rodriguez-Rovira, Isaac
  • Pérez Jurado, Luis Alberto
  • Egea, Gustavo
  • Campuzano Uceda, María Victoria
Williams-Beuren syndrome (WBS) is a rare disorder caused by a recurrent microdeletion with hallmarks of cardiovascular manifestations, mainly supra-valvular aortic stenosis (SVAS). Unfortunately, there is currently no efficient treatment. We investigated the effect of chronic oral treatment with curcumin and verapamil on the cardiovascular phenotype of a murine model of WBS harbouring a similar deletion, CD (complete deletion) mice. We analysed systolic blood pressure in vivo and the histopathology of the ascending aorta and the left ventricular myocardium to determine the effects of treatments and their underlying mechanism. Molecular analysis showed significantly upregulated xanthine oxidoreductase (XOR) expression in the aorta and left ventricular myocardium of CD mice. This overexpression is concomitant with increased levels of nitrated proteins as a result of byproduct-mediated oxidative stress damage, indicating that XOR-generated oxidative stress impacts the pathophysiology of cardiovascular manifestations in WBS. Only the combined therapy of curcumin and verapamil resulted in a significant improvement of cardiovascular parameters via activation of the nuclear factor erythroid 2 (NRF2) and reduction of XOR and nitrated protein levels. Our data suggested that the inhibition of XOR and oxidative stress damage could help prevent the severe cardiovascular injuries of this disorder., This research was funded by Ministerio de Ciencia e Innovación (AEI/MINEICO/FEDER, UE), grant number: SAF2016-78508-R to V.C. and PID2020-113634RB-C2 to G.E.; from Association “Autour des Williams” to V.C.; and Generalitat de Catalunya (2017-SGR1794) to L.A.P.J.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The combined treatment of curcumin with verapamil ameliorates the cardiovascular pathology in a Williams-Beuren syndrome mouse model

  • Abdalla, Noura
  • Ortiz Romero, Paula, 1994-
  • Rodriguez-Rovira, Isaac
  • Pérez Jurado, Luis Alberto
  • Egea, Gustavo
  • Campuzano Uceda, María Victoria
Williams-Beuren syndrome (WBS) is a rare disorder caused by a recurrent microdeletion with hallmarks of cardiovascular manifestations, mainly supra-valvular aortic stenosis (SVAS). Unfortunately, there is currently no efficient treatment. We investigated the effect of chronic oral treatment with curcumin and verapamil on the cardiovascular phenotype of a murine model of WBS harbouring a similar deletion, CD (complete deletion) mice. We analysed systolic blood pressure in vivo and the histopathology of the ascending aorta and the left ventricular myocardium to determine the effects of treatments and their underlying mechanism. Molecular analysis showed significantly upregulated xanthine oxidoreductase (XOR) expression in the aorta and left ventricular myocardium of CD mice. This overexpression is concomitant with increased levels of nitrated proteins as a result of byproduct-mediated oxidative stress damage, indicating that XOR-generated oxidative stress impacts the pathophysiology of cardiovascular manifestations in WBS. Only the combined therapy of curcumin and verapamil resulted in a significant improvement of cardiovascular parameters via activation of the nuclear factor erythroid 2 (NRF2) and reduction of XOR and nitrated protein levels. Our data suggested that the inhibition of XOR and oxidative stress damage could help prevent the severe cardiovascular injuries of this disorder., This research was funded by Ministerio de Ciencia e Innovación (AEI/MINEICO/FEDER, UE), grant number: SAF2016-78508-R to V.C. and PID2020-113634RB-C2 to G.E.; from Association “Autour des Williams” to V.C.; and Generalitat de Catalunya (2017-SGR1794) to L.A.P.J.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Hyperuricaemia Does Not Interfere with Aortopathy in a Murine Model of Marfan Syndrome

  • Rodríguez-Rovira, Isaac
  • López-Sainz, Angela|||0000-0001-7433-2137
  • Palomo-Buitrago, Maria Encarnación
  • Pérez, Belén|||0000-0001-5801-1704
  • Jiménez Altayó, Francesc|||0000-0002-9034-2041
  • Campuzano, Victoria|||0000-0001-8128-2641
  • Egea, Gustavo|||0000-0001-5242-150X
Redox stress is involved in the aortic aneurysm pathogenesis in Marfan syndrome (MFS). We recently reported that allopurinol, a xanthine oxidoreductase inhibitor, blocked aortopathy in a MFS mouse model acting as an antioxidant without altering uric acid (UA) plasma levels. Hyperuricaemia is ambiguously associated with cardiovascular injuries as UA, having antioxidant or pro-oxidant properties depending on the concentration and accumulation site. We aimed to evaluate whether hyperuricaemia causes harm or relief in MFS aortopathy pathogenesis. Two-month-old male wild-type (WT) and MFS mice (Fbn1C1041G/+) were injected intraperitoneally for several weeks with potassium oxonate (PO), an inhibitor of uricase (an enzyme that catabolises UA to allantoin). Plasma UA and allantoin levels were measured via several techniques, aortic root diameter and cardiac parameters by ultrasonography, aortic wall structure by histopathology, and pNRF2 and 3-NT levels by immunofluorescence. PO induced a significant increase in UA in blood plasma both in WT and MFS mice, reaching a peak at three and four months of age but decaying at six months. Hyperuricaemic MFS mice showed no change in the characteristic aortic aneurysm progression or aortic wall disarray evidenced by large elastic laminae ruptures. There were no changes in cardiac parameters or the redox stress-induced nuclear translocation of pNRF2 in the aortic tunica media. Altogether, the results suggest that hyperuricaemia interferes neither with aortopathy nor cardiopathy in MFS mice.